avagacestat,
BMS 708163,
BMS-708163,
BMS708163,
Avagacestat,
BMS-708163,
1146699-66-2,
BMS-708163 (Avagacestat),
BMS 708163,
Avagacestat (BMS-708163),
UNII-TQ44WWY45Q,
BMS-708163-01,
TQ44WWY45Q,
(2R)-2-[N-[(4-CHLOROPHENYL)SULFONYL]-N-[2-FLUORO-4-(1,2,4-OXADIAZOL-3-YL)BENZYL]AMINO]-5,5,5-TRIFLUOROPENTANAMIDE,
(R)-2-(4-chloro-N-(2-fluoro-4-(1,2,4-oxadiazol-3-yl)benzyl)phenylsulfonamido)-5,5,5-trifluoropentanamide,
(2R)-2-[(4-Chlorophenyl)sulfonyl-[[2-fluoro-4-(1,2,4-oxadiazol-3-yl)phenyl]methyl]amino]-5,5,5-trifluoro-pentanamide,
(2R)-5,5,5-trifluoro-2-(N-{[2-fluoro-4-(1,2,4-oxadiazol-3-yl)phenyl]methyl}4-chlorobenzenesulfonamido)pentanamide,
(R)-2-(4-Chloro-N-(2-fluoro-4-(1,2,4-oxadiazol-3-yl)benzyl)-phenylsulfonamido)-5,5,5-trifluoropentanamide,
Avagacestat [USAN:INN],
BMS708163,
Avagacestat (USAN),
C20H17ClF4N4O4S,
MLS006011074,
SCHEMBL310019,
GTPL6489,
CHEMBL1090771,
Avagacestat, >=98% (HPLC),
DTXSID40150811,
XEAOPVUAMONVLA-QGZVFWFLSA-N,
BCPP000327,
BCP01770,
BBL102113,
MFCD13195458,
s1262,
STL555912,
ZINC43202993,
AKOS005146523,
AKOS016016280,
BCP9000429,
CS-0180,
DB11893,
RL00571,
SB19495,
MRF-0000009,
NCGC00346504-01,
(2R)-2-(N-((4-Chlorophenyl)sulfonyl)-N-((2-fluoro-4-(1,2,4-oxadiazol-3-yl)phenyl)methyl)amino)-5,5,5-trifluoropentanamide,
BC640339,
HY-50845,
SMR004676648,
BCP0726000124,
AB0033799,
AX8165413,
DB-024955,
FT-0772942,
SW218162-2,
X7561,
D09869,
W-5573,
123886-EP2295417A1,
699B662,
BMS708163, 1146699-66-2,
(2R)-2-[(4-chlorophenyl)sulfonyl-[[2-fluoro-4-(1,2,4-oxadiazol-3-yl)phenyl]methyl]amino]-5,5,5-trifluoropentanamide,
(2R)-2-[[(4-chlorophenyl)-sulfonyl][[2-fluoro-4-(1,2,4-oxadiazol-3-yl)phenyl]methyl]amino]-5,5,5-trifluoropentanamide,
(2R)-2-[[(4-Chlorophenyl)sulfonyl][[2-fluoro-4-(1,2,4-oxadiazol-3-yl)phenyl]methyl]amino]-5,5,5-trifluoro-pentanamide,
(2R)-2-[[(4-Chlorophenyl)sulfonyl][[2-fluoro-4-(1,2,4-oxadiazol-3-yl)phenyl]methyl]amino]-5,5,5-trifluoropentanamide,
N~2~-[(4-chlorophenyl)sulfonyl]-5,5,5-trifluoro-N~2~-[2-fluoro-4-(1,2,4-oxadiazol-3-yl)benzyl]-D-norvalinamide,
Pentanamide, 2-[[(4-chlorophenyl)sulfonyl][[2-fluoro-4-(1,2,4-oxadiazol-3-yl)phenyl]methyl]amino]-5,5,5-trifluoro-, (2R)-,
Avagacestat [USAN],
D02JOH,
cc-297,
A4022,
A10157,
C554092,